Original Research

Published on 24 Jun 2022

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model

in Pharmacology of Infectious Diseases

Abrianna Beever
Nala Kachour
James Owens
Kayvan Sasaninia
Afsal Kolloli
Ranjeet Kumar
Santhamani Ramasamy
Christina Sisliyan
Wael Khamas
Selvakumar Subbian

Frontiers in Pharmacology

doi 10.3389/fphar.2022.879729

2,725 views
12 citations

Original Research

Published on 21 Jun 2022

Risk Factors Associated With Prolonged Antibiotic Use in Pediatric Bacterial Meningitis

in Pharmacology of Infectious Diseases

Cuiyao He
Xiaogang Hu
Tingsong Li
Qing Wu
Jisan Fan
Yan Zhou
Li Jiang
Siqi Hong
Yuanyuan Luo

Frontiers in Pharmacology

doi 10.3389/fphar.2022.904322

2,259 views
1 citation

Original Research

Published on 17 Jun 2022

Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis

in Pharmacology of Infectious Diseases

Edilaine S. Xavier
Rafael L. de Souza
Vinícius C. Rodrigues
Camila O. Melo
Daniel B. Roquini
Bruna L. Lemes
Polrat Wilairatana
Elquio E. Oliveira
Josué de Moraes

Frontiers in Pharmacology

doi 10.3389/fphar.2022.917363

2,929 views
15 citations

Original Research

Published on 16 Jun 2022

Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy

in Pharmacology of Infectious Diseases

Xu-ben Yu
Xiao-Shan Zhang
Ye-Xuan Wang
Yu-Zhen Wang
Hong-Min Zhou
Fang-Min Xu
Jun-Hui Yu
Li-Wen Zhang
Ying Dai
Zi-Ye Zhou

Frontiers in Pharmacology

doi 10.3389/fphar.2022.915958

4,238 views
19 citations

Review

Published on 13 Jun 2022

Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review

in Pharmacology of Infectious Diseases

Samuel J. M. Hale
Brett Wagner Mackenzie
Christian A. Lux
Kristi Biswas
Raymond Kim
Richard G. Douglas

Frontiers in Pharmacology

doi 10.3389/fphar.2022.840323

7,952 views
9 citations

Original Research

Published on 08 Jun 2022

Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools

in Pharmacology of Infectious Diseases

Yong Jiang
Yi-Zi Xie
Chen-Wen Peng
Kai-Nan Yao
Xue-Ying Lin
Shao-Feng Zhan
Hong-Fa Zhuang
Hui-Ting Huang
Xiao-Hong Liu
Xiu-Fang Huang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.865097

4,407 views
12 citations

Original Research

Published on 07 Jun 2022

Remedial Aspect of Zinc Oxide Nanoparticles Against Serratia Marcescens and Enterococcus Faecalis

in Pharmacology of Infectious Diseases

Sinouvassane Djearamane
Zhe Chi Loh
Jun Jie Lee
Ling Shing Wong
Ranjithkumar Rajamani
Priscy Alfredo Luque
Piyush Kumar Gupta
Sharolynne Xiao Tong Liang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.891304

2,904 views
12 citations

Original Research

Published on 06 Jun 2022

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment

in Pharmacology of Infectious Diseases

Xiangqing Song
Yi Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.890748

2,218 views
3 citations

Systematic Review

Published on 03 Jun 2022

Benefits and Risks of Rapid Initiation of Antiretroviral Therapy: A Systematic Review and Meta-Analysis

in Pharmacology of Infectious Diseases

Ruojing Bai
Juan Du
Shiyun Lv
Wei Hua
Lili Dai
Hao Wu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.898449

4,393 views
8 citations

Original Research

Published on 03 Jun 2022

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

in Pharmacology of Infectious Diseases

Si-Yu Yuan
Hai-Bo Yu
Zhen Yang
Yi-Ping Qin
Ji-Hua Ren
Sheng-Tao Cheng
Fang Ren
Betty Yuen Kwan Law
Vincent Kam Wai Wong
Jerome P. L. Ng

Frontiers in Pharmacology

doi 10.3389/fphar.2022.837115

3,090 views
2 citations

Original Research

Published on 02 Jun 2022

Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19

in Pharmacology of Infectious Diseases

Zhenjie Zhuang
Xiaoying Zhong
Qianying Chen
Huiqi Chen
Zhanhua Liu

Frontiers in Pharmacology

doi 10.3389/fphar.2022.857730

3,916 views
4 citations

Mini Review

Published on 02 Jun 2022

Next-Generation Approaches Needed to Tackle Antimicrobial Resistance for the Development of Novel Therapies Against the Deadly Pathogens

in Pharmacology of Infectious Diseases

Vasundhra Bhandari
Akash Suresh

Frontiers in Pharmacology

doi 10.3389/fphar.2022.838092

5,439 views
8 citations

Original Research

Published on 02 Jun 2022

A Cyclic Disulfide Diastereomer From Bioactive Fraction of Bruguiera gymnorhiza Shows Anti–Pseudomonas aeruginosa Activity

in Pharmacology of Infectious Diseases

Nilesh Lakshman Dahibhate
Sanjeev K. Shukla
Kundan Kumar

Frontiers in Pharmacology

doi 10.3389/fphar.2022.890790

1,711 views
4 citations

Review

Published on 27 May 2022

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)

in Pharmacology of Infectious Diseases

Daniela Milani
Lorenzo Caruso
Enrico Zauli
Adi Mohammed Al Owaifeer
Paola Secchiero
Giorgio Zauli
Donato Gemmati
Veronica Tisato

Frontiers in Pharmacology

doi 10.3389/fphar.2022.871583

12,712 views
24 citations

Original Research

Published on 27 May 2022

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children

in Pharmacology of Infectious Diseases

Xuedong Jia
Zhao Yin
Wan Zhang
Conghui Guo
Shuzhang Du
Xiaojian Zhang

Frontiers in Pharmacology

doi 10.3389/fphar.2022.902054

2,113 views
5 citations

Perspective

Published on 20 May 2022

Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19

in Pharmacology of Infectious Diseases

Barbara Bortot
Arianna Romani
Giuseppe Ricci
Stefania Biffi

Frontiers in Pharmacology

doi 10.3389/fphar.2022.877422

2,247 views
5 citations

Navigation group

Articles

L-GSH Supplementation in Conjunction With Rifampicin Augments the Treatment Response to Mycobacterium tuberculosis in a Diabetic Mouse Model

Risk Factors Associated With Prolonged Antibiotic Use in Pediatric Bacterial Meningitis

Therapeutic Efficacy of Carvacrol-Loaded Nanoemulsion in a Mouse Model of Schistosomiasis

Population Pharmacokinetics of Colistin Sulfate in Critically Ill Patients: Exposure and Clinical Efficacy

Topical Antibiofilm Agents With Potential Utility in the Treatment of Chronic Rhinosinusitis: A Narrative Review

Modeling Kaempferol as a Potential Pharmacological Agent for COVID-19/PF Co-Occurrence Based on Bioinformatics and System Pharmacological Tools

Remedial Aspect of Zinc Oxide Nanoparticles Against Serratia Marcescens and Enterococcus Faecalis

Predicted Vancomycin Dosage Requirement in Patients With Hematological Malignancies and Dosage Dynamic Adjustment

Benefits and Risks of Rapid Initiation of Antiretroviral Therapy: A Systematic Review and Meta-Analysis

Pimobendan Inhibits HBV Transcription and Replication by Suppressing HBV Promoters Activity

Bioinformatics and System Biology Approach to Reveal the Interaction Network and the Therapeutic Implications for Non-Small Cell Lung Cancer Patients With COVID-19

Next-Generation Approaches Needed to Tackle Antimicrobial Resistance for the Development of Novel Therapies Against the Deadly Pathogens

A Cyclic Disulfide Diastereomer From Bioactive Fraction of Bruguiera gymnorhiza Shows Anti–Pseudomonas aeruginosa Activity

p53/NF-kB Balance in SARS-CoV-2 Infection: From OMICs, Genomics and Pharmacogenomics Insights to Tailored Therapeutic Perspectives (COVIDomics)

Effectiveness and Nephrotoxicity of Intravenous Polymyxin B in Carbapenem-Resistant Gram-Negative Bacterial Infections Among Chinese Children

Exploiting Extracellular Vesicles Strategies to Modulate Cell Death and Inflammation in COVID-19